Hypoxia and Prostate Cancer Aggressiveness: A Tale With Many Endings
- 1 August 2015
- journal article
- review article
- Published by Elsevier BV in Clinical Genitourinary Cancer
- Vol. 13 (4), 295-301
- https://doi.org/10.1016/j.clgc.2015.03.006
Abstract
No abstract availableThis publication has 79 references indexed in Scilit:
- Lysyl Oxidase, Extracellular Matrix Remodeling and Cancer MetastasisCancer Microenvironment, 2012
- Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not AnticipateCancer Cell, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- LKB1 inhibits lung cancer progression through lysyl oxidase and extracellular matrix remodelingProceedings of the National Academy of Sciences of the United States of America, 2010
- Antibody-specific detection of CAIX in breast and prostate cancersBiochemical and Biophysical Research Communications, 2009
- Lysyl oxidase propeptide inhibits prostate cancer cell growth by mechanisms that target FGF-2-cell binding and signalingOncogene, 2009
- Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: a retrospective analysis of two randomised radiotherapy trials and one surgical cohort studyThe Lancet Oncology, 2008
- Notch signaling mediates hypoxia-induced tumor cell migration and invasionProceedings of the National Academy of Sciences of the United States of America, 2008
- Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancerBritish Journal of Cancer, 2007
- Hypoxia — a key regulatory factor in tumour growthNature Reviews Cancer, 2002